Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis
- 1 March 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 27 (3), 428-434
- https://doi.org/10.1016/j.cmi.2020.04.007
Abstract
No abstract availableKeywords
Funding Information
- ZAMBON-PHARMA
This publication has 22 references indexed in Scilit:
- Adult Patients With BronchiectasisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2017
- Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research CollaborationEuropean Respiratory Journal, 2016
- A Comprehensive Analysis of the Impact ofPseudomonas aeruginosaColonisation on Prognosis in Adult BronchiectasisAnnals of the American Thoracic Society, 2015
- PROGNOSIS – das deutsche Bronchiektasen-RegisterPneumologie, 2015
- Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED scoreEuropean Respiratory Journal, 2014
- The Bronchiectasis Severity Index. An International Derivation and Validation StudyAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Long‐term macrolides for non‐cystic fibrosis bronchiectasis: A systematic review and meta‐analysisRespirology, 2014
- Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Lung function decline in COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis BronchiectasisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007